secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001140361-23-052908
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers Squibb completes $4.5B note offering to finance Mirati acquisition
--------------------------------------------------------------------------------

- $4.5B note offering completed: $1B 5.75% due 2031, $1B 5.9% due 2033, $1.25B 6.25% due 2053, $1.25B 6.4% due 2063.
- Proceeds to fund general corporate purposes, including the proposed acquisition of Mirati Therapeutics.
- Offering closed November 13, 2023; underwritten by syndicate of banks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/0001140361-23-052908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-052908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer